Clinical Trials on Breast Fibrocystic Disease in United Kingdom
Total 147128 results
-
The Leeds Teaching Hospitals NHS TrustUnknownBreast CancerUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
University of OxfordNational Institute for Health Research, United KingdomEnrolling by invitationBreast Cancer | Risk ReductionUnited Kingdom
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
University of GlasgowUnknown
-
Cambridge University Hospitals NHS Foundation TrustUnknownBreast Cancer | Perioperative/Postoperative Complications | Cardiac ToxicityUnited Kingdom
-
NHS TaysideUniversity of DundeeCompleted
-
University Hospitals Bristol and Weston NHS Foundation...RecruitingHER2 Negative Metastatic Breast CancerUnited Kingdom
-
Hoffmann-La RocheCompletedBreast CancerSpain, France, United States, United Kingdom
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
AstraZenecaCompletedPostmenopausal Women With ER+ HER2- Primary Breast CancerGermany, United Kingdom
-
Mayo ClinicCompletedBreast Cancer | Dense BreastsUnited States
-
Mayo ClinicCompleted
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; National Institute for Health Research Biomedical...Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
Imperial College LondonRecruitingBreast Cancer | Mobility LimitationUnited Kingdom
-
Warwick Medical SchoolUnknown
-
Cohera Medical, Inc.Completed
-
Royal Marsden NHS Foundation TrustUnknownMastalgia | Breast PainUnited Kingdom
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Pancreatic CancerUnited States, United Kingdom
-
Clear Cut Medical Ltd.Recruiting
-
Lytix Biopharma ASICON plc; TheradexCompletedMelanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast CancerUnited Kingdom, France, Norway, Belgium, Italy
-
Eisai LimitedCompletedBreast CancerUnited Kingdom, Denmark, Ireland
-
GlaxoSmithKlineCompletedNeoplasms, BreastGermany, United Kingdom, France, Argentina
-
Imperial College LondonAstraZeneca; Cancer Research UKCompleted
-
BerGenBio ASAMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IVSpain, United States, United Kingdom, Norway
-
Karolinska InstitutetRecruitingBreast CancerSweden, Finland, Australia, United Kingdom
-
Novartis PharmaceuticalsUniversity of Sheffield; Danish Breast Cancer Cooperative GroupCompletedHormone Sensitive Resected Primary Breast Cancer in Postmenopausal WomenDenmark, United Kingdom
-
University of St AndrewsSwansea University; University of Surrey; Chief Scientist Office of the Scottish... and other collaboratorsUnknownBreast Cancer | Fear of CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingAdvanced Breast CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
NeoDynamics ABRecruitingBreast CancerUnited Kingdom
-
Eisai LimitedCompletedMetastatic Breast CancerUnited Kingdom, Bulgaria, Russian Federation
-
Birmingham City UniversityCompletedBody Temperature Changes | Breast FeedingUnited Kingdom
-
The Christie NHS Foundation TrustCompletedBreast Cancer | Multiple Myeloma | Gastrointestinal Cancer | Gynaecological CancerUnited Kingdom
-
Ellipses PharmaRecruitingMetastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States, Spain, United Kingdom
-
Genentech, Inc.Active, not recruitingBreast Cancer | Solid TumorUnited States, France, Spain, United Kingdom, Canada
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
Cytori TherapeuticsCompletedBreast Neoplasms | Carcinoma, Ductal, Breast | Mammaplasty | Mastectomy, Segmental, Lumpectomy, Breast Reconstruction,Spain, United Kingdom, Belgium, Italy
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
European Organisation for Research and Treatment...TerminatedBreast CancerFrance, Belgium, United Kingdom, Slovenia, Germany
-
University of WarwickPublic Health EnglandEnrolling by invitationBreast Cancer | Ductal Carcinoma in SituUnited Kingdom
-
European Organisation for Research and Treatment...CompletedBreast CancerFrance, Belgium, Netherlands, Slovenia, United Kingdom
-
Queen's University, BelfastBelfast Health and Social Care Trust; Cancer Research NetworkTerminatedBreast Neoplasms | Colorectal NeoplasmsUnited Kingdom
-
Bournemouth UniversityCompletedBreast Milk CollectionUnited Kingdom
-
ImunonUnknownBreast CancerUnited States, United Kingdom
-
University College London (UCL) Cancer InstituteUnknownBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Esophageal Cancer | Lung CancerUnited Kingdom
-
Cardiff and Vale University Health BoardCompleted
-
National Cancer Research NetworkUnknown
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia